{{Rsnum
|rsid=690347
|Gene=ZFYVE19
|Chromosome=15
|position=40813728
|Orientation=plus
|ReferenceAllele=T
|MissenseAllele=G
|GMAF=0.1841
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=ZFYVE19
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 54.9 | 34.5 | 10.6
| HCB | 89.8 | 10.2 | 0.0
| JPT | 85.0 | 15.0 | 0.0
| YRI | 72.1 | 25.9 | 2.0
| ASW | 54.4 | 33.3 | 12.3
| CHB | 89.8 | 10.2 | 0.0
| CHD | 83.5 | 16.5 | 0.0
| GIH | 55.4 | 35.6 | 8.9
| LWK | 56.4 | 38.2 | 5.5
| MEX | 82.8 | 15.5 | 1.7
| MKK | 66.7 | 27.6 | 5.8
| TSI | 58.8 | 34.3 | 6.9
| HapMapRevision=28
}}{{Venter SNP
|rsid=690347
|allele=G
|frequency=0.84
|uid=1103645593857
|type=homozygous_SNP
|hugo=ZFYVE19
|ensembl gene=ENSG00000166140
|ensembl transcript=ENST00000355341
|sift=TOLERATED
|disease=A chromosomal aberration involving ZFYVE19 is associated with acute myeloblastic leukemia (AML). Translocation t(11;15)(q23;q14) with MLL/HRX.
}}

{{GET Evidence
|gene=ZFYVE19
|aa_change=Ser376Ala
|aa_change_short=S376A
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs690347
|overall_frequency_n=7737
|overall_frequency_d=10288
|overall_frequency=0.752041
|n_genomes=53
|n_genomes_annotated=0
|n_haplomes=94
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.001
|nblosum100=-1
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}